Vacuolar protein sorting-associated protein 29 (VPS29)

Vacuolar protein sorting-associated protein 29 (VPS29) is a highly conserved adapter protein that forms a core component of the Retromer, Retriever, and Commander complexes, which are essential for endosomal sorting and recycling of membrane proteins in eukaryotic cells[1][2][3][7]. VPS29 contains a phosphoesterase fold, but it is catalytically inactive and instead serves as a structural scaffold, mediating assembly through protein–protein interactions rather than enzymatic activity[5][6]. The protein binds tightly to VPS35 and functions as a context-dependent subunit, shaping Retromer and Retriever activities. Multiple VPS29 isoforms exist, including VPS29A, VPS29B, and VPS29C, with alternative splicing altering the N-terminal sequence and consequently modulating its interactions and assembly specificity[1][3]. VPS29 regulates endosomal trafficking, retrograde transport from endosomes to the trans-Golgi network, and is crucial for neural and general cellular homeostasis. Reduced Retromer expression or mutations in VPS29 are implicated in neurodegenerative disorders such as Alzheimer's and familial Parkinson's disease[1][3][7]. Notes on therapeutic targeting: VPS29 itself is not currently the direct target of approved drugs, but Retromer stabilization (which involves VPS29) is a potential therapeutic strategy in neurodegenerative disease research due to its central role in clearing amyloidogenic and other pathologic cargoes[1][3]. No known clinical biomarkers or direct interacting drugs are cataloged for VPS29 as a lone target. Modulation of core Retromer components may have widespread effects due to the complexity and essential nature of endosomal-lysosomal system regulation.

Other names

DC15DC7MDS007hVPS29PEP11retromer proteinvesicle protein sorting 29vacuolar protein sorting 29 homologvacuolar sorting protein VPS29/PEP11epididymis secretory sperm binding proteinx 007 protein

Not a direct drug target currently; potential therapeutic strategies involve modulation of Retromer function or stabilization (indirectly altering VPS29 activity)